Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Bifurcation Lesions Market Size Changed, over the years?

The market size for bifurcation lesions has witnessed significant growth in the past few years. The market, which will rise from $2.63 billion in 2024, is projected to flourish to $2.86 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 8.5%. The historical growth of this market can be attributed to the increasing prevalence of coronary artery diseases, a growing geriatric population, increased healthcare spending, and overall economic growth.

How Much Will the Bifurcation Lesions Market Be Worth in 2029?

The market size for bifurcation lesions is poised for impressive growth in the coming years, predicted to reach $4.02 billion in 2029 with a compound annual growth rate (CAGR) of 8.9%. Factors contributing to the anticipated growth during the forecast period include a rising need for minimally invasive procedures, the development and expansion of healthcare infrastructure, increasing instances of cardiovascular conditions and government healthcare regulations. Critical trends during this period will be patient-focused strategies, the utilisation of bioresorbable stents, incorporation of artificial intelligence and machine learning, as well as cross-discipline cooperation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7414&type=smp

Which is the Largest Company in the Bifurcation Lesions Market?

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

What Are the Main Market Drivers in the Bifurcation Lesions Industry?

The rise in the elderly population is anticipated to boost the bifurcation lesions market’s expansion. Those over 60 are more susceptible to heart attacks, strokes, coronary heart disease and heart failure than those who are younger. Bifurcation lesions come in handy in such situations to help deal with blood clots and ensure the heart receives sufficient blood supply. For instance, a report released by the World Health Organisation (WHO), a Switzerland-based international public health agency, in October 2022, projected that by 2030, every sixth person globally will be at least 60 years old. By 2050, nearly 2.1 billion people globally will be 60 or older. Comparing with the current population, the count of individuals 80 years or older will spike by 426 million between 2020 and 2050. Thus, the escalating elderly population will propel the growth of the bifurcation lesions market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7414&type=smp

How Is the Bifurcation Lesions Market Segments Structured?

The bifurcation lesions market covered in this report is segmented –

1) By Types: One-Stent, Two-Stent

2) By Application: Coronary Vascular, Peripheral Vascular

Subsegments:

1) By One-Stent: Single-Stent Deployment, Balloon-Expandable Stents, Self-Expanding Stents

2) By Two-Stent: Crush Technique, T- or Y-Configuration Stenting, Side Branch Stenting Techniques

What Strategic Trends Are Transforming the Bifurcation Lesions Market?

The proliferation of enhanced imaging and procedure-based devices is a significant trend gaining traction in the bifurcation lesions market. Principal companies active in the market are rigorously focusing on enriching the features of existing diagnostic and procedural tools. One such example is Advanced Bifurcation Systems (ABS), a clinical-stage medical equipment company that aims to standardize the treatment of all bifurcation lesions during coronary angioplasties through its unique bifurcation stenting solution. The only modular self-aligning stent technology that evenly structures bifurcations is offered in the ABS platform. This exceptional single system decreases the necessity for repeat actions and facilitates an efficient bifurcation stenting treatment.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

Which Global Regions Offer the Highest Growth in the Bifurcation Lesions Market?

North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bifurcation lesions market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7414

This Report Delivers Insight On:

1. How big is the bifurcation lesions market, and how is it changing globally?

2. Who are the major companies in the bifurcation lesions market, and how are they performing?

3. What are the key opportunities and risks in the bifurcation lesions market right now?

4. Which products or customer segments are growing the most in the bifurcation lesions market?

5. What factors are helping or slowing down the growth of the bifurcation lesions market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model